707 related articles for article (PubMed ID: 28161590)
1. Granulocyte-macrophage colony-stimulating factor-dependent CD11c-positive cells differentiate into active osteoclasts.
Ruef N; Dolder S; Aeberli D; Seitz M; Balani D; Hofstetter W
Bone; 2017 Apr; 97():267-277. PubMed ID: 28161590
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro.
Balani D; Aeberli D; Hofstetter W; Seitz M
Arthritis Rheum; 2013 Feb; 65(2):436-46. PubMed ID: 23124514
[TBL] [Abstract][Full Text] [Related]
3. TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF.
Atanga E; Dolder S; Dauwalder T; Wetterwald A; Hofstetter W
Bone; 2011 Nov; 49(5):1090-100. PubMed ID: 21884837
[TBL] [Abstract][Full Text] [Related]
4. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue.
Hattersley G; Chambers TJ
J Cell Physiol; 1990 Jan; 142(1):201-9. PubMed ID: 2153687
[TBL] [Abstract][Full Text] [Related]
5. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
[TBL] [Abstract][Full Text] [Related]
7. The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells.
Fujikawa Y; Sabokbar A; Neale SD; Itonaga I; Torisu T; Athanasou NA
Bone; 2001 Mar; 28(3):261-7. PubMed ID: 11248655
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-3 and granulocyte-macrophage colony-stimulating factor inhibits tumor necrosis factor (TNF)-alpha-induced osteoclast differentiation by down-regulation of expression of TNF receptors 1 and 2.
Yogesha SD; Khapli SM; Wani MR
J Biol Chem; 2005 Mar; 280(12):11759-69. PubMed ID: 15653694
[TBL] [Abstract][Full Text] [Related]
9. Effects of macrophage colony stimulating factor and granulocyte-macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells.
Liggett W; Shevde N; Anklesaria P; Sohoni S; Greenberger J; Glowacki J
Stem Cells; 1993 Sep; 11(5):398-411. PubMed ID: 8241951
[TBL] [Abstract][Full Text] [Related]
10. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA
Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352
[TBL] [Abstract][Full Text] [Related]
11. Presence of osteoclast precursors in colonies cloned in the presence of hematopoietic colony-stimulating factors.
Yamazaki H; Kunisada T; Yamane T; Hayashi SI
Exp Hematol; 2001 Jan; 29(1):68-76. PubMed ID: 11164107
[TBL] [Abstract][Full Text] [Related]
12. Role of colony-stimulating factors in osteoclast development.
Takahashi N; Udagawa N; Akatsu T; Tanaka H; Shionome M; Suda T
J Bone Miner Res; 1991 Sep; 6(9):977-85. PubMed ID: 1724107
[TBL] [Abstract][Full Text] [Related]
13. Induction of macrophagic and granulocytic differentiation of murine bone marrow progenitor cells by 1,25-dihydroxyvitamin D3.
Orikasa M; Kawase T; Suzuki A
Calcif Tissue Int; 1993 Sep; 53(3):193-200. PubMed ID: 8242472
[TBL] [Abstract][Full Text] [Related]
14. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
15. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
16. Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF.
Hodge JM; Kirkland MA; Aitken CJ; Waugh CM; Myers DE; Lopez CM; Adams BE; Nicholson GC
J Bone Miner Res; 2004 Feb; 19(2):190-9. PubMed ID: 14969388
[TBL] [Abstract][Full Text] [Related]
17. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
Gorny G; Shaw A; Oursler MJ
Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony stimulating factor suppresses lipopolysaccharide-induced osteoclast-like cell formation in mouse bone marrow cultures.
Shuto T; Jimi E; Kukita T; Hirata M; Koga T
Endocrinology; 1994 Feb; 134(2):831-7. PubMed ID: 8299579
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-3 plays dual roles in osteoclastogenesis by promoting the development of osteoclast progenitors but inhibiting the osteoclastogenic process.
Hong H; Shi Z; Qiao P; Li H; McCoy EM; Mao P; Xu H; Feng X; Wang S
Biochem Biophys Res Commun; 2013 Nov; 440(4):545-50. PubMed ID: 24103757
[TBL] [Abstract][Full Text] [Related]
20. Derivation of osteoclasts from hematopoietic colony-forming cells in culture.
Kerby JA; Hattersley G; Collins DA; Chambers TJ
J Bone Miner Res; 1992 Mar; 7(3):353-62. PubMed ID: 1585838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
